Background Therapeutic antibodies targeting EGFR have activity in advanced colorectal
cancer, but results from clinical trials are inconsistent and the population in which most benefit …

Patients with hematological malignancies are at increased risk of severe COVID-19 outcomes
due to compromised immune responses, but the insights of these studies have been …

Background The interim analysis of the multicentre New EPOC trial in patients with resectable
colorectal liver metastasis showed a significant reduction in progression-free survival in …

Background Initial results from the ongoing GALLIUM trial have shown that patients with
follicular lymphoma have a longer progression-free survival after first-line immunochemotherapy …

Individuals with lymphoid malignancies are at risk of developing severe COVID-19 and are
less likely to develop protective immune responses to SARS-CoV-2 vaccination than the …

Background Pre-clinical models demonstrate that platelet activation is involved in the spread
of malignancy. Ongoing clinical trials are assessing whether aspirin, which inhibits platelet …

BACKGROUND The growing teratoma syndrome is a recognized complication of metastatic
nonseminomatous germ cell tumors of the testis and is managed surgically. It may also …

Purpose: We have clinically evaluated a DNA fusion vaccine to target the HLA-A*0201–binding
peptide CAP-1 from carcinoembryonic antigen (CEA 605–613 ) linked to an …

People with blood cancers have an increased risk of severe COVID-19 disease despite booster
vaccine doses. 1 This group, like other disease groups at increased risk of severe COVID…

The precise etiology of autism remains unclear. Obstetric adversity has been described as
one factor that may increase the risk for the disorder. We examined the contemporaneous …